PharmiWeb.com - Global Pharma News & Resources

Marketing - Press Releases

Date Title Company
19-Dec-2019 World first treatment with ‘acoustic cluster therapy’ to improve chemotherapy delivery The Institute of Cancer Research, London,
19-Dec-2019 Nobel Prize winning research prompts new cancer treatments GlobalData
19-Dec-2019 David Hale appointed CEO of Guerbet as from January 1, 2020 to accelerate deployment of the Group's strategy Guerbet
19-Dec-2019 Median Technologies announces the signing of a € 35 million finance contract with the European Investment Bank (EIB) Median Technologies
19-Dec-2019 Sartorius Establishes Scientific Advisory Board The Sartorius Group
19-Dec-2019 Parkinson’s symptoms are improved with weekly regimens that include physical and cognitive exercises The Physiological Society
19-Dec-2019 Phoenix Solutions Enters Clinical Phase The Institute of Cancer Research
19-Dec-2019 PureTech Health Affiliate Follica Announces Positive Topline Data from Clinical Study in Male Androgenetic Alopecia PureTech Health plc
19-Dec-2019 Syncona makes further $80 million commitment to Freeline Freeline
18-Dec-2019 HRA PHARMA ANNOUNCES INTERNATIONAL EXPANSION HRA Pharma
18-Dec-2019 PureTech Health Affiliate Gelesis Announces Partnership with Ro to Support US Commercialisation of Plenity TM Gelesis
18-Dec-2019 XBiotech Added to NASDAQ Biotechnology Index XBiotech
18-Dec-2019 MR Solutions participates in the first nanomedicine joint annual meeting in Dijon MR Solutions
18-Dec-2019 Domain Therapeutics and Pr Michel Bouvier (IRIC Montreal) receive the RSRI award for bioSens-All™ project at ADRIQ-RCTi Innovation Prize gala Domain Therapeutics
18-Dec-2019 Sanofi Wins Prestigious Drug Discovery Award for Innovative Rare Blood Clotting Disorder Treatment[1] Sanofi
18-Dec-2019 Newcells Biotech Win Phase II of CRACK IT Challenge 29: ImmuLiver Newcells Biotech
18-Dec-2019 World first treatment with ‘acoustic cluster therapy’ to improve chemotherapy delivery The Institute of Cancer Research
18-Dec-2019 Vaccitech Oncology Limited enters collaboration with Cancer Research UK to fund a Phase I/IIa clinical trial as first-line NSCLC therapy Vaccitech Ltd
17-Dec-2019 Novartis receives positive CHMP opinion for Beovu® (brolucizumab) for the treatment of wet AMD Novartis UK
17-Dec-2019 NICE recommends Vifor Pharma’s Veltassa® (patiromer) for adults with hyperkalaemia in England[i] Vifor Pharma UK